Slingshot’s revolutionary technology is a new paradigm for any cell-based application, including drug discovery, clinical trials, medical testing, and cell therapy manufacturing.
Drug development, diagnostics and adoptive cell therapies without limitations—that’s the world we envisioned when we founded this company over 10 years ago. We cut our teeth in academia, in R&D and in the clinics where we learned first-hand the limitations of biologically-derived cellular reagents: resource-intensive products that fall short in performance and accuracy, unstable and inconsistent over time, and a complex, ethically-challenged supply chain—all leading to unequal access to the most basic diagnostic testing and life-saving therapies.
We knew there had to be a better way. And there is.
We applied the tenets of biochemistry, high-precision manufacturing and polymer chemistry to create FlowCytes™. These shelf-stable, synthetic cells can be custom printed on demand, at scale, in real-time. Slingshot’s revolutionary technology decreases cost, shortens development timelines and increases stability, impact and accessibility. There is a new paradigm for drug development, diagnostics and cell therapy—one without limitations.
Through our pursuit of global leadership in the research, development, and production of breakthrough cell technologies, we aim to unlock new possibilities for human health.
We bring together the brightest and most dedicated minds from every culture and corner of the world, united by a common purpose: to advance science with passion, integrity, and imagination. In this spirit of collaboration, we cultivate innovation, challenge boundaries, and embrace diversity as the catalyst of discovery.
Our impact will grow through expansion of meaningful partnerships—with researchers across industry, academia, and government—enabling them to achieve their goals faster and with greater confidence. We empower our partners by delivering products and services of the highest quality, while upholding every ethical, legal, and regulatory standard.
With unwavering commitment, we will continue to innovate, invest, and refine our Quality Management Systems, our people, and our processes to consistently deliver excellence.
Our vision is to advance the understanding of cell biology, especially in cancer and rare diseases, to help scientists and physicians focus on what they do best—creating innovative cures to treat patients.
We aim to replace biological cells in diagnostic and therapeutic industries that have been held back by limitations in sourcing, supply chain and bio-based reagents. In doing so, our vision is to simplify workflows by removing cost barriers, enabling greater access to all patients.
We imagine a future where patients are treated with a drug that is personally designed for their needs. In that vision, our platform technologies will unlock the potential to custom design therapeutics quickly, reliably and at scale for our biopharma partners.
By using this website, you agree to the storing of cookies on your device. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy.
